New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
UNHCR, the UN Refugee Agency works to ensure that everybody has the right to ... This winter, our teams are dealing with vastly different crises across Europe, Asia, the Middle East and North Africa, ...
Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
3d
GlobalData on MSNEMA establish advisory portal for high-risk medical devicesThe EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.
In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...
Column: Trump isn't an isolationist. He's a bully — and that's hurting U.S. influence in the world
Trump was labeled 'isolationist' over disdain for alliances. That doesn't fit a president who says he's willing to send ...
Nadine Ferris France was in Nairobi when she read the email that brought international development aid to a shuddering halt.
Since Beijing and Washington imposed tariffs on each other's goods this month, Western media have been closely monitoring whether the trade war will ...
Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results